Safely Returning to Clinical Trials
Since the coronavirus pandemic started, clinical trial recruitment and enrollment is down 40-60% across therapeutic areas. As the quarantine period ends, we are left with many questions about how to safely move forward with research, especially for patients suffering from serious, life-threatening diseases that might increase their risk of dying from COVID-19. This session will bring together the experts who sponsor, conduct, staff, and recruit clinical trials to discuss the challenges and potential solutions that will enable continued access to novel, life-saving medications for patients around the world.
Kathryn (Kate) Owen
Dr. Amy C. Moore
Upal Basu Roy PhD, MPH
Christopher D. Ferris MD, PhD, MPH